Publicacións en colaboración con investigadores/as de Universitat de València (45)

2018

  1. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain

    European Journal of Pediatrics, Vol. 177, Núm. 2, pp. 181-192

2016

  1. Linderiella baetica Alonso & García-de-Lomas 2009 (Crustacea, Branchiopoda, Anostraca): ¿al borde de la extinción?

    Revista de la Sociedad Gaditana de Historia Natural: RSGHN, Vol. 10, pp. 15-26

  2. Seroprevalence of pertussis amongst healthcare professionals in Spain

    Vaccine, Vol. 34, Núm. 8, pp. 1109-1114

2015

  1. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial

    Vaccine, Vol. 33, Núm. 6, pp. 789-795

2011

  1. Becton Dickinson Directigen EZ Flu A+B assay in the diagnosis of pandemic influenza A H1N1 2009 virus infection in adult patients

    Influenza and other Respiratory Viruses

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

2008

  1. Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide

    Journal of Hospital Infection, Vol. 68, Núm. 3, pp. 248-254

2007

  1. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 1, pp. 68-76

  2. Influence of Haemophilus influenzae β-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins

    International Journal of Antimicrobial Agents

  3. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: Age-related differences

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 206-210

2006

  1. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with prevenar in children with underlying chronic or recurrent lung diseases

    Clinical and Vaccine Immunology, Vol. 13, Núm. 6, pp. 665-670

2005

  1. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-haemolytic streptococci in 2002-2003: Results of the multinational GRASP Surveillance Program

    International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 148-156

  2. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

2002

  1. Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: The SAUCE project

    Journal of Antimicrobial Chemotherapy, Vol. 50, Núm. SUPPL. 2, pp. 21-26

2000

  1. Immunological diagnosis of human hydatid cyst relapse: Utility of the enzyme-linked immunoelectrotransfer blot and discriminant analysis

    Clinical and Diagnostic Laboratory Immunology, Vol. 7, Núm. 4, pp. 549-552

1999

  1. Acreditacion y certificacion de laboratorios de microbiologia clinica? Si, pero son adecuados ENAC y AENOR?

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Immunological diagnosis of human cystic echinococcosis: Utility of discriminant analysis applied to the enzyme-linked immunoelectrotransfer blot

    Clinical and Diagnostic Laboratory Immunology, Vol. 6, Núm. 4, pp. 504-508

  3. Low prevalence of diphtheria immunity in the Spanish population: Results of a cross-sectional study

    Vaccine, Vol. 17, Núm. 15-16, pp. 1978-1982

1998

  1. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 17, Núm. 6, pp. 420-423

  2. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections

    Chemotherapy, Vol. 44, Núm. 2, pp. 94-98